WIM
ALXN
Westside Investment Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,459
| Closed | -$819 | – | 786 |
|
|
2021
Q2 | $819 | Sell |
4,459
-4,842
| -52% | -$889 | ﹤0.01% | 251 |
|
|
2021
Q1 | $1.42K | Hold |
9,301
| – | – | ﹤0.01% | 227 |
|
|
2020
Q4 | $1.45K | Sell |
9,301
-110
| -1% | -$17 | ﹤0.01% | 182 |
|
|
2020
Q3 | $1.08K | Buy |
9,411
+1,230
| +15% | +$141 | ﹤0.01% | 202 |
|
|
2020
Q2 | $918 | Buy |
8,181
+130
| +2% | +$15 | ﹤0.01% | 184 |
|
|
2020
Q1 | $722 | Buy |
+8,051
| New | +$722 | ﹤0.01% | 192 |
|
|
2019
Q2 | $699 | Buy |
+5,344
| New | +$699 | ﹤0.01% | 131 |
|
|
2018
Q4 | $522K | Buy |
5,365
+770
| +17% | +$75K | 0.19% | 89 |
|
|
2018
Q3 | $630K | Hold |
4,595
| – | – | 0.2% | 77 |
|
|
2018
Q2 | $574K | Buy |
4,595
+230
| +5% | +$28.8K | 0.2% | 79 |
|
|
2018
Q1 | $474K | Buy |
4,365
+640
| +17% | +$69.5K | 0.26% | 85 |
|
|
2017
Q4 | $446K | Hold |
3,725
| – | – | 0.24% | 92 |
|
|
2017
Q3 | $526K | Hold |
3,725
| – | – | 0.32% | 74 |
|
|
2017
Q2 | $461K | Buy |
3,725
+2,975
| +397% | +$368K | 0.3% | 79 |
|
|
2017
Q1 | $87.2K | Buy |
+750
| New | +$87.2K | 0.04% | 203 |
|